Table 4.

Patients receiving oncofertility information

	AYA survivors who underwent chemotherapy
	No. of patients provided information on fertility damage/methods to preserve fertility (%)	No. of patients provided information on fertility damage/methods to preserve fertility before cancer therapy (%)
Total number (n = 115)	65/37 (56.0/31.9)	35/26 (30.2/22.4)
Excluding breast cancer (n = 92)	44/20 (47.8/21.7)	17/12 (18.5/13.0)
Breast cancer (n = 23)	21/17 (91.3/73.9)	18/14 (78.3/60.9)
Hematological diseases (n = 55)	26/10 (47.3/18.2)	9/6 (16.4/10.9)
Excluding breast cancer and hematological diseases (n = 37)	18/10 (48.6/2.7)	8/6 (21.6/16.2)
AYA at primary diagnosis (n = 52)	42/29 (80.8/55.8)	29/22 (55.8/42.3)

AYA, adolescent and young adults.